Barclays
RXO icon

Barclays’s RXO RXO Stock Holding History

Barclays’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$771K Sell
27,954
-2,227
-7% -$49.2K ﹤0.01% 2949
2026
Q1 		$441K Sell
30,181
-227,943
-88% -$3.35M ﹤0.01% 3262
2025
Q4 		$3.26M Sell
258,124
-17,372
-6% -$256K ﹤0.01% 2566
2025
Q3 		$4.24M Sell
275,496
-21,859
-7% -$352K ﹤0.01% 2332
2025
Q2 		$4.67M Buy
297,355
+93,786
+46% +$1.42M ﹤0.01% 2190
2025
Q1 		$3.89M Sell
203,569
-81,625
-29% -$1.79M ﹤0.01% 2114
2024
Q4 		$6.8M Sell
285,194
-623,679
-69% -$17.4M ﹤0.01% 1887
2024
Q3 		$25.4M Buy
908,873
+590,530
+186% +$16.7M 0.01% 947
2024
Q2 		$8.32M Buy
318,343
+26,093
+9% +$543K ﹤0.01% 1270
2024
Q1 		$6.39M Sell
292,250
-48,513
-14% -$1.04M ﹤0.01% 1686
2023
Q4 		$7.93M Buy
340,763
+69,997
+26% +$1.41M ﹤0.01% 1711
2023
Q3 		$5.34M Buy
270,766
+203,052
+300% +$4M ﹤0.01% 1288
2023
Q2 		$1.54M Buy
67,714
+24,941
+58% +$502K ﹤0.01% 2056
2023
Q1 		$840K Buy
42,773
+18,996
+80% +$365K ﹤0.01% 2871
2022
Q4 		$409K Buy
+23,777
New +$422K ﹤0.01% 3436

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Barclays's RXO Position: Q2 2026 in Review

Barclays reduced its RXO (RXO) stake by 7.4% in Q2 2026, selling an estimated $49.2K and leaving 27,954 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

Barclays first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $25.4M in Q3 2024. 305 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Barclays held 27,954 shares of RXO worth $771K as of Q2 2026.
  • Barclays sold 2,227 RXO shares in Q2 2026, an estimated $49.2K.
  • RXO made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2949 holding.
  • Barclays first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Barclays's RXO position peaked at $25.4M in Q3 2024.
  • 305 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.